在败血症中METTL3-介导的m6A修饰:当前的证据和未来的前景
Zijun Wu1,2,3, Changhong Miao1,2,3, Hao Zhang1,2,3
1Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Epigenomics
|April 19, 2025
概括
败血症是一种严重的感染反应,缺乏特定的治疗方法. 本综述探讨了N6-甲基氨酸 (m6A) 和它的作者METTL3如何影响败血症病理.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 败血症是一种危及生命的全身性炎症状况,死亡率高.
- 尽管有进展,但缺乏特定的败血症治疗方法.
- 基因表观RNA修饰,特别是N6-甲基氨酸 (m6A),正在引起人们的注意.
研究的目的:
- 审查败血症的病理机制.
- 为了阐明m6A和败血症之间的关系.
- 专注于METTL3的作用,一个关键的m6A作家,在败血症.
主要方法:
- 关于败血症病理学的文献综述.
- 对炎症性疾病中的m6A研究的分析.
- 专注于详细研究METTL3功能在败血症模型中的研究.
主要成果:
- m6A修饰在败血症的发病过程中起着重要作用.
- 作为主要的m6A甲基转移酶,METTL3参与了在败血症期间调节炎症反应.
- m6A和METTL3的失调有助于败血症的严重程度和结果.
结论:
- m6A和METTL3是败血症的关键调节剂.
- 针对m6A通路,特别是METTL3,可能为败血症提供新的治疗策略.
- 对基于m6A的干预措施的进一步研究对于败血症治疗有必要.
相关概念视频
Protein Modifications in the RER
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


